ASP Isotopes, Inc. (ASPI)
NASDAQ:ASPI
Want to see ASPI full AI Analyst Report?
ASPI Stock Chart & Stats
$5.34
<$0.01(0.11%)
At close: 4:00 PM EST
$5.34
<$0.01(0.11%)
Day’s Range― - ―
52-Week Range$3.92 - $14.49
Previous Close$4.79
Volume1.39M
Average Volume (3M)5.64M
Market Cap
$824.67M
Enterprise Value$700.99M
Total Cash (Recent Filing)$290.52M
Total Debt (Recent Filing)$261.84M
Price to Earnings (P/E)―
Beta2.01
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding125,903,450
10 Day Avg. Volume6,314,928
30 Day Avg. Volume5,636,470
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)2.18
Price to Sales (P/S)18.62
P/FCF Ratio-9.36
Enterprise Value/Market Cap0.85
Enterprise Value/Revenue26.03
Enterprise Value/Gross Profit147.76
Enterprise Value/Ebitda-4.11
Forecast
1Y Price Target
$11.00Price Target Upside105.99% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth & Gross MarginSustained high revenue growth coupled with a healthy gross margin signals durable end-market demand and initial pricing power for core isotope products. This supports scalable gross profits as production capacity ramps, enabling reinvestment in facilities and R&D to capture long-term market opportunities.
Strong Cash CushionA multi-year cash runway materially reduces liquidity and short-term refinancing risk during multi-year facility builds. It allows management to fund capital-intensive enrichment projects and absorb execution delays without immediate dilution, supporting strategic expansion over the next several years.
Strategic Acquisition & Industry DiversificationAcquiring Renergen diversifies ASP Isotopes into helium/LNG and related gas infrastructure, broadening product and end-market exposure into electronics and space. New operational leadership and asset synergies can strengthen supply chain control and create cross-selling and scale benefits over the medium term.
Bears Say
Persistent UnprofitabilityMaterial negative net and EBIT margins indicate core operations are not yet generating sustainable profits. Continued losses constrain self-funded growth, raise reliance on external financing, and heighten dilution or refinancing risk while the company scales capital-intensive enrichment facilities.
High Financial LeverageA debt-to-equity ratio above 4x imposes significant fixed obligations and limits financial flexibility. With ongoing losses, high leverage raises refinancing and interest-rate sensitivity, increasing the chance that capital costs or covenant pressures could slow facility builds or force operational trade-offs.
Execution & Regulatory DelaysPermitting setbacks and prior equipment failures create a persistent execution risk for new enrichment plants. Delays push out revenue realization, inflate development costs, and complicate commitments like take-or-pay contracts, making multi-site expansion and integration timelines uncertain over the coming months.
ASP Isotopes, Inc. News
ASPI FAQ
What was ASP Isotopes, Inc.’s price range in the past 12 months?
ASP Isotopes, Inc. lowest stock price was $3.92 and its highest was $14.49 in the past 12 months.
What is ASP Isotopes, Inc.’s market cap?
ASP Isotopes, Inc.’s market cap is $824.67M.
When is ASP Isotopes, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ASP Isotopes, Inc.’s earnings last quarter?
Currently, no data Available
Is ASP Isotopes, Inc. overvalued?
According to Wall Street analysts ASP Isotopes, Inc.’s price is currently Undervalued.
Does ASP Isotopes, Inc. pay dividends?
ASP Isotopes, Inc. does not currently pay dividends.
What is ASP Isotopes, Inc.’s EPS estimate?
ASP Isotopes, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ASP Isotopes, Inc. have?
ASP Isotopes, Inc. has 125,903,450 shares outstanding.
What happened to ASP Isotopes, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ASP Isotopes, Inc.?
Currently, no hedge funds are holding shares in ASPI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ASP Isotopes, Inc. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.00 (105.99% Upside)
$11.00 (105.99% Upside)
Blogger Sentiment
Neutral
ASPI Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 145.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 0.8%
Last 30 Days ▼ 0.8%
Technicals
SMA
Negative
20 days / 200 days
Momentum
9.73%
12-Months-Change
Fundamentals
Return on Equity
-117.16%
Trailing 12-Months
Asset Growth
546.69%
Trailing 12-Months
Company Description
ASP Isotopes, Inc.
ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.
ASPI Stock 12 Month Forecast
Average Price Target
$11.00
▲(105.99% Upside)
Technical Analysis
Ownership Overview
13.46% Insiders
6.85% Mutual Funds
19.46% Other Institutional Investors
48.15% Public Companies and Individual Investors